Publications by authors named "D P Benziger"

Claim this Profile
S
Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
John S Bradley, David Benziger, Paula Bokesch, Richard Jacobs

Pediatr Infect Dis J· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levels.
Steven D Burdette, Frederick Oleson, Patrick M McDaneld, David Benziger, Hina N Patel

Am J Health Syst Pharm· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment.
Ricardo L Chaves, Abhijit Chakraborty, David Benziger, Stacey Tannenbaum

J Antimicrob Chemother· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of intravenous ceftolozane-tazobactam in healthy adult subjects following single and multiple ascending doses.
Benjamin Miller, Ellie Hershberger, David Benziger, Mymy Trinh, Ian Friedland

Antimicrob Agents Chemother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections.
Susan M Abdel-Rahman, Gurudatt Chandorkar, Ronda L Akins, John S Bradley, Richard F Jacobs, David P Benziger

Pediatr Infect Dis J· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis